"Meili" LLC
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sergeenko, Artem
NCT05030324: A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Recruiting
2
255
RoW
XC221 100 mg, XC221 200 mg, Placebo
Valenta Pharm JSC
Influenza, Viral Respiratory Infection, Acute Viral Upper Respiratory Infections
12/21
12/21

Download Options